← Eichor
Condition: Oral And Throat Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Oral And Throat Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · 153 location(s) · NRG Oncology · NCT06532279Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy
NA · 20 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT05892354Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the Ex
NA · 4 location(s) · Institut Claudius Regaud · NCT05757817Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Phase N/A · 1 location(s) · Viome · NCT05451303BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or S
Phase 2 · 225 location(s) · National Cancer Institute (NCI) · NCT05136196Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07209189Biospecimen Procurement for Head and Neck Disorders
Phase N/A · 9 location(s) · National Cancer Institute (NCI) · NCT03429036Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Phase 1 · 18 location(s) · National Cancer Institute (NCI) · NCT05172245Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.
NA · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05719779Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
NA · 4 location(s) · Medical University of South Carolina · NCT05793151Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
Phase 2 · 7 location(s) · M.D. Anderson Cancer Center · NCT04870762Oropharynx (OPX) Biomarker Trial
Phase N/A · 1 location(s) · Mayo Clinic · NCT06356272Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
NA · 1 location(s) · Vanessa Torrecillas · NCT07264036High-Resolution PET-CT Imaging for Surgical Margin Visualization
NA · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT06915454Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Phase 2 · 100 location(s) · National Cancer Institute (NCI) · NCT07195734DESTINY-PANTUMOUR04
Phase N/A · 18 location(s) · AstraZeneca · NCT07124000Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Can
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT00900419Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest
Phase 2 · 1 location(s) · Mayo Clinic · NCT06997068A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07063212Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer
Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT04754321Enhancing Oral Cancer Awareness
NA · 1 location(s) · Virginia Commonwealth University · NCT06682494Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
Phase N/A · 18 location(s) · University Hospital Freiburg · NCT05337631Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT07156227Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spre
Phase 3 · 192 location(s) · National Cancer Institute (NCI) · NCT06589804Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis
Phase N/A · 5 location(s) · Nanfang Hospital, Southern Medical University · NCT06307314Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objective
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT01365169Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
Phase 1 · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT06819228Arabic PRO Measures for Head and Neck Cancer Radiotherapy.
Phase N/A · 1 location(s) · King Saud University · NCT06662929The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
Phase N/A · 10 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT05483374Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.